RxDoctor Payments Data

Lisa Murillo, APRN

Family · Hopkinsville, KYNPI 1124423025

Payments from drug & device makers

$511in general payments, 2019–2025

Across 22 payments — averaging $23.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lundbeck LLC$99
  • Johnson & Johnson$97
  • Neurocrine Biosciences, Inc.$84
  • Teva Pharmaceuticals USA, Inc.$64
  • Otsuka America Pharmaceutical, Inc.$41
  • Indivior Inc.$23
  • plus $103 from 5 others

What the payments were for

  • Food & beverage$511100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$511 in reported general payments places this provider in the 50th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$2,165
Medicare patients
37
Services billed
55

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide34$18,219
OzempicSemaglutide17$17,446
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,678
XareltoRivaroxaban13$7,617
Breo ElliptaFluticasone/Vilanterol15$5,521
FarxigaDapagliflozin Propanediol13$3,775
JardianceEmpagliflozin12$3,652
Pantoprazole Sodium27$3,551
Calcitriol11$1,283
Atorvastatin Calcium111$1,170
Insulin Glargine-Yfgn13$918
FenofibrateFenofibrate Nanocrystallized24$741
Levothyroxine Sodium49$674
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst44$651
Pravastatin Sodium25$600

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$97$7,61713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,374 family providers in Kentucky.

Other family in Hopkinsville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →